SNY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today, Sanofi's share price is $46.18. Sanofi's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2014 was $17.05. Hence, Sanofi's P/S Ratio for today is 2.71.
During the past 13 years, Sanofi's highest P/S Ratio was 5.18. The lowest was 1.72. And the median was 2.84.
Sanofi revenue has been in decline over the past 3 years.
During the past 3 years, the average Revenue per Share Growth Rate was -1.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was 1.50% per year. During the past 10 years, the average Revenue per Share Growth Rate was 4.10% per year.
During the past 13 years, Sanofi's highest 3-Year average Revenue per Share Growth Rate was 27.40% per year. The lowest was -1.50% per year. And the median was 7.20% per year.
The P/S Ratio is another ratio widely used to value stocks. It was first used by Ken Fisher.
Sanofi's P/S Ratio for today is calculated as
|P/S Ratio||=||Share Price||/||Revenue per Share (TTM)|
Sanofi's Share Price of today is $46.18.
Sanofi's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2014 was 4.44 (Dec. 2013 ) + 4.15 (Mar. 2014 ) + 4.11 (Jun. 2014 ) + 4.35 (Sep. 2014 ) = $17.05.
It can also be calculated from the numbers for the whole company:
The revenue here is for the trailing 12 months.
The P/S ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The P/S ratio works especially well when you want to compare the stocks current valuation with its historical valuation. The P/S ratio is a great valuation tool for evaluating cyclical businesses where the P/E ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a companys profit margin tends to revert to the mean.
When the P/S ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
Similar to the Price/Earnings ratio and Price/Cash Flow or Price/Free Cash Flow, the P/E ratio measures the valuation based on the earning power of the company. This is where it is different from Price/Book ratio, which measures the valuation based on the companys balance sheet.
The P/S ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Sanofi Annual Data
Sanofi Quarterly Data
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.